Comprehensive Online Oncology Database
New Medicine Oncology KnowledgeBASE
NEWS
SUBSCRIBER SEARCH
(Requires Login)
NEW DRUG
MARKETED DRUG
COMPANY
TARGETS IN ONCOLOGY
NEWS AND WEBCAST SUMMARIES
COMBINATION TRIALS
  
   1-949-830-0448   info@newmedinc.com   
 
ABOUT nm|OK
nm|OK FREE ACCESS AND DEMO
APPLICATIONS
DESCRIPTION OF MODULES
INQUIRIES AND FEEDBACK
LICENSE AGREEMENT
PRIVACY POLICY
SAMPLE QUERY SCREENS
SAMPLE REPORTS & RECORDS
SOURCES
SUBSCRIPTION INFORMATION
USER GUIDE

PRODUCTS AND SERVICES
FUTURE ONCOLOGY
FEATURED IN-DEPTH REPORTS
CUSTOM REPORT REQUEST

NEWS
NEWS SUMMARIES
LATEST nm|OK UPDATES
nm|OK NEWS RELEASES

SITE MAP
Having trouble finding something?
Use our site map.
 

Latest Updates
April 2008 Marketed Drug Updates and Additions

Brand Name
Generic Name
Other Designation
Abraxane Nanoparticle albumin-bound (nab) paclitaxel, paclitaxel albumin bound (PAB) ABI-007
AC Vaccine M-Vax (Mela Vax)    
Calsed Amrubicin hydrochloride SM-5887, SMP-5887
Collatamp G, Collatamp EG, Sulmycin Implant, Garamycin Schwamm, Duracoll, Garacoll, Garacol, Gentacoll, Gentacol, Gentalyn and Cronocol    
Velcade Bortezomib MLN341 (formerly LDP-341, PS-341 & MG-341)
Gleevec (USA, Canada, Israel), Glivec (Europe) Imatinib mesylate STI-571, STI571, formerly CGP-57148B
Fareston, Acapodene Toremifene FC-1157, FC-1157a, NK-622, GTx-006
Tarceva Erlotinib CP 358774, OSI-774, R1415, NSC 718781
Amnolake, Amnoid, Amnoleuk, Tamibaro Tamibarotene Am80, Am-80, TOS-80T


HOME   |   NEW MEDICINE   |   SITE MAP

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM